文献速递乳腺乳腺X线

雌激素受体阳性乳腺癌绝经前女性停用他莫昔芬后乳腺X线摄影密度的变化

Mammographic density changes following discontinuation of tamoxifen in premenopausal women with oestrogen receptor-positive breast cancer.
PubMed 文献 · Eur Radiol · 2018-04-06

本研究纳入213例接受他莫昔芬治疗的雌激素受体阳性乳腺癌绝经前女性,评估停药后乳腺X线摄影密度变化。定性评估显示31.9%(68/213,读片者1)至22.1%(47/213,读片者2)出现密度增加,定量评估平均密度增加1.8%。多因素分析显示年龄≤39岁和治疗后密度下降≥17.0%是停药后密度变化的独立相关因素(p < .001和p = .003)。

要点

  • 停用他莫昔芬后部分绝经前乳腺癌患者乳腺X线密度增加,定量平均增加1.8%。
  • 年龄≤39岁及他莫昔芬治疗期间密度下降≥17.0%与停药后密度变化独立相关。
  • 定性评估密度增加的比例因读片者而异(31.9% vs 22.1%)。

核心结论

  • 停用他莫昔芬与乳腺X线摄影密度变化相关,平均密度增加1.8%,且与较年轻年龄和治疗后密度下降幅度较大相关。

研究设计与样本

  • 连续纳入213例接受他莫昔芬治疗并完成三次乳腺X线摄影(基线、他莫昔芬治疗后、停药后)的绝经前乳腺癌患者,定性评估由两名读片者完成,定量采用半自动软件测量。

关键影像表现/征象

  • 停药后定性评估密度增加见于31.9%(68/213,读片者1)至22.1%(47/213,读片者2)的患者。
  • 定量评估显示停药后平均密度较停药前增加1.8%。

诊断标准与关键数值

  • 定性密度变化分为减少、无变化或增加。
  • 多因素分析显示年龄≤39岁与停药后密度变化独立相关(p < .001)。
  • 他莫昔芬治疗后密度下降≥17.0%与停药后密度变化独立相关(p = .003)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the changes in mammographic density after tamoxifen discontinuation in premenopausal women with oestrogen receptor-positive breast cancers and the underlying factors METHODS: A total of 213 consecutive premenopausal women with breast cancer who received tamoxifen treatment after curative surgery and underwent three mammograms (baseline, after tamoxifen treatment, after tamoxifen discontinuation) were included. Changes in mammographic density after tamoxifen discontinuation were assessed qualitatively (decrease, no change, or increase) by two readers and measured quantitatively by semi-automated software. The association between % density change and clinicopathological factors was evaluated using univariate and multivariate regression analyses.

RESULTS: After tamoxifen discontinuation, a mammographic density increase was observed in 31.9% (68/213, reader 1) to 22.1% (47/213, reader 2) by qualitative assessment, with a mean density increase of 1.8% by quantitative assessment compared to density before tamoxifen discontinuation. In multivariate analysis, younger age (≤ 39 years) and greater % density decline after tamoxifen treatment (≥ 17.0%) were independent factors associated with density change after tamoxifen discontinuation (p < .001 and p = .003, respectively).

CONCLUSIONS: Tamoxifen discontinuation was associated with mammographic density change with a mean density increase of 1.8%, which was associated with younger age and greater density change after tamoxifen treatment.

KEY POINTS: • Increased mammographic density after tamoxifen discontinuation can occur in premenopausal women. • Mean density increase after tamoxifen discontinuation was 1.8%. • Density increase is associated with age and density decrease after tamoxifen.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Kim WH, Cho N, Kim YS, et al. Mammographic density changes following discontinuation of tamoxifen in premenopausal women with oestrogen receptor-positive breast cancer. Eur Radiol. 2018. PMID: 29626240. doi:10.1007/s00330-017-5293-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。